October 26, 2015 24.06 19 March 2013
Technology appraisal. Apixaban for the prevention of stroke and systemic embolism in people with nonvalvular atrial fibrillation with one or more risk factor for stroke or systemic embolism.
New from NICE
PrescriberMailing list request
Registration is for health professionals only and gives free access to our content.
Your Name (required)
Your Email (required)
Job Title (required)
---CCGCommunity NurseCommunity PharmacistGPGP prescribing leadNon-medical PrescriberPractice NursePractice PharmacistOther (specify below)
Other Job Title
Would you also like to receive the print title?
Yes (please complete address details below)No
Address Line 1
Address Line 2
By submitting your email address you consent to receive occasional relevant email alerts from Prescriber. Your email will not be shared with any third party. Please note you can opt out by replying to any email with the words ‘unsubscribe’.